Latest Crohn's disease Stories
NEW YORK, May 19, 2015 /PRNewswire/ -- In honor of today being World IBD Day, The Crohn's & Colitis Foundation of America (CCFA) and the European Federation of Crohn's &
ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia(®) (certolizumab
-- More than 40,000 patients to participate NEW YORK, May 13, 2015 /PRNewswire-USNewswire/ -- The Crohn's & Colitis
BALTIMORE, May 6, 2015 /PRNewswire/ -- University of Maryland (UM) Ventures and
NEW YORK and ANN ARBOR, Mich., April 30, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough immunomodulatory medicines to treat autoimmune diseases and cancer,
Center for Integrative Studies in Inflammatory Bowel Disease New York, NY (PRWEB) April 27, 2015 The Sanford J.
NEW YORK, April 21, 2015 /PRNewswire-USNewswire/ -- More than 40 countries across the globe are joining together this year in a unified effort to raise awareness about Crohn's disease and
PRINCETON, N.J., April 14, 2015 /PRNewswire/ -- Soligenix, Inc.
NEW YORK, April 13, 2015 /PRNewswire-USNewswire/ -- In an effort to raise support for patients and families dealing with inflammatory bowel diseases (IBD), the Crohn's & Colitis Foundation of America
Stem cells may provide Crohn’s disease sufferers relief from a common, potentially dangerous side effect – fistulas – according to the results of a phase 2 clinical trial published in the
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.